Exchange Announcement • 21 Nov 2024 11:45
Exchange Announcement • 21 Nov 2024 11:35
Exchange Announcement • 20 Nov 2024 14:42
Exchange Announcement • 20 Nov 2024 13:56
Exchange Announcement • 19 Nov 2024 14:58
ENTITY
Paradigm Biopharmaceuticals (PAR AU)
Paradigm Biopharmaceuticals (PAR AU)
20
Analysis
Health Care • Australia
Paradigm Biopharmaceuticals Limited operates as a biopharmaceutical company. The Company develops PPS drug to treat respiratory diseases such as allergic asthma, allergic rhinitis, and chronic obstructive pulmonary. Paradigm Biopharmaceuticals offers its services in Australia.
more
x